Sylvia Stadlmann

Baden, AG 5404, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Histologic Diagnosis of Intravascular Large B-Cell Lymphoma After Endovascular Thrombectomy: A Case Report of a Rare and Incidental Finding.

Histologic Diagnosis of Intravascular Large B-Cell Lymphoma After Endovascular Thrombectomy: A Case Report of a Rare and Incidental Finding.

Journal: Reports (MDPI)

Published: June 04, 2026

Recurrence-free survival is prolonged in high-grade serous ovarian cancer with high PD-L1 expression.

Recurrence-free survival is prolonged in high-grade serous ovarian cancer with high PD-L1 expression.

Journal: BMC cancer

Published: October 22, 2025

High density of CXCL12-positive immune cell infiltration predicts chemosensitivity and recurrence-free survival in ovarian carcinoma.

High density of CXCL12-positive immune cell infiltration predicts chemosensitivity and recurrence-free survival in ovarian carcinoma.

Journal: Journal of cancer research and clinical oncology

Published: July 03, 2023

Pathologist Computer-Aided Diagnostic Scoring of Tumor Cell Fraction: A Swiss National Study.

Pathologist Computer-Aided Diagnostic Scoring of Tumor Cell Fraction: A Swiss National Study.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: May 31, 2023

Hormone Receptor Expression in Primary and Recurrent High-Grade Serous Ovarian Cancer and Its Implications in Early Maintenance Treatment.

Hormone Receptor Expression in Primary and Recurrent High-Grade Serous Ovarian Cancer and Its Implications in Early Maintenance Treatment.

Journal: International journal of molecular sciences

Published: September 04, 2022

The Role of New Technologies in the Diagnosis and Surveillance of Non-Muscle Invasive Bladder Carcinoma: A Prospective, Double-Blinded, Monocentric Study of the XPERT© Bladder Cancer Monitor and Narrow Band Imaging© Cystoscopy.

The Role of New Technologies in the Diagnosis and Surveillance of Non-Muscle Invasive Bladder Carcinoma: A Prospective, Double-Blinded, Monocentric Study of the XPERT© Bladder Cancer Monitor and Narrow Band Imaging© Cystoscopy.

Journal: Cancers

Published: December 05, 2021

High ratio of pCXCR4/CXCR4 tumor infiltrating immune cells in primary high grade ovarian cancer is indicative for response to chemotherapy.

High ratio of pCXCR4/CXCR4 tumor infiltrating immune cells in primary high grade ovarian cancer is indicative for response to chemotherapy.

Journal: BMC cancer

Published: October 18, 2021

High Density of CD16+ Tumor-Infiltrating Immune Cells in Recurrent Ovarian Cancer Is Associated with Enhanced Responsiveness to Chemotherapy and Prolonged Overall Survival.

High Density of CD16+ Tumor-Infiltrating Immune Cells in Recurrent Ovarian Cancer Is Associated with Enhanced Responsiveness to Chemotherapy and Prolonged Overall Survival.

Journal: Cancers

Published: October 15, 2021

Long-Lasting Complete Remission of Small-Cell Carcinoma of the Pancreas with Carboplatin and Etoposide Complicated by Gallbladder Adenocarcinoma Diagnosed during Follow-Up.

Long-Lasting Complete Remission of Small-Cell Carcinoma of the Pancreas with Carboplatin and Etoposide Complicated by Gallbladder Adenocarcinoma Diagnosed during Follow-Up.

Journal: Case reports in oncology

Published: December 15, 2020

Viropathic multinuclear syncytial giant cells in bronchial fluid from a patient with COVID-19.

Viropathic multinuclear syncytial giant cells in bronchial fluid from a patient with COVID-19.

Journal: Journal of clinical pathology

Published: April 30, 2020

High density of CD66b in primary high-grade ovarian cancer independently predicts response to chemotherapy.

High density of CD66b in primary high-grade ovarian cancer independently predicts response to chemotherapy.

Journal: Journal of cancer research and clinical oncology

Published: November 22, 2019

High OX40 expression in recurrent ovarian carcinoma is indicative for response to repeated chemotherapy.

High OX40 expression in recurrent ovarian carcinoma is indicative for response to repeated chemotherapy.

Journal: BMC cancer

Published: November 18, 2017

Showing 1-12 of 21

Last Updated: 09/26/2026